Question 1

Am I eligible for this trial based on my recent surgery and cancer type?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Erlotinib in Post Radical Operation NSCLC Patients With EGFR Mutation clinical trial (NCT01683175). Contact the study team or your healthcare provider for specific answers.

Question 2

How does erlotinib compare to the chemotherapy options I might receive?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Erlotinib in Post Radical Operation NSCLC Patients With EGFR Mutation clinical trial (NCT01683175). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of erlotinib versus chemotherapy?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Erlotinib in Post Radical Operation NSCLC Patients With EGFR Mutation clinical trial (NCT01683175). Contact the study team or your healthcare provider for specific answers.

Question 4

How often would I need to come in for treatment and monitoring?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Erlotinib in Post Radical Operation NSCLC Patients With EGFR Mutation clinical trial (NCT01683175). Contact the study team or your healthcare provider for specific answers.

Question 5

What should I expect during the study, and how will my health be monitored?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Erlotinib in Post Radical Operation NSCLC Patients With EGFR Mutation clinical trial (NCT01683175). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any risks associated with participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Erlotinib in Post Radical Operation NSCLC Patients With EGFR Mutation clinical trial (NCT01683175). Contact the study team or your healthcare provider for specific answers.

What this study is about